rs142438319
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000123.4(ERCC5):c.2281G>A(p.Ala761Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000932 in 1,614,044 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A761V) has been classified as Uncertain significance.
Frequency
Consequence
NM_000123.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ERCC5 | NM_000123.4 | c.2281G>A | p.Ala761Thr | missense_variant | 10/15 | ENST00000652225.2 | |
BIVM-ERCC5 | NM_001204425.2 | c.3643G>A | p.Ala1215Thr | missense_variant | 18/23 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ERCC5 | ENST00000652225.2 | c.2281G>A | p.Ala761Thr | missense_variant | 10/15 | NM_000123.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000664 AC: 101AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000445 AC: 112AN: 251422Hom.: 0 AF XY: 0.000405 AC XY: 55AN XY: 135886
GnomAD4 exome AF: 0.000960 AC: 1403AN: 1461842Hom.: 1 Cov.: 30 AF XY: 0.000942 AC XY: 685AN XY: 727226
GnomAD4 genome ? AF: 0.000664 AC: 101AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.000592 AC XY: 44AN XY: 74354
ClinVar
Submissions by phenotype
Xeroderma pigmentosum, group G Uncertain:3
Uncertain significance, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | Sep 21, 2015 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Sep 27, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 134160). This variant has not been reported in the literature in individuals affected with ERCC5-related conditions. This variant is present in population databases (rs142438319, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 761 of the ERCC5 protein (p.Ala761Thr). - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 03, 2022 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in individuals with melanoma and other cancers, but also in unaffected controls (Pritchard 2018); This variant is associated with the following publications: (PMID: 24728327, 25801821, 29641532) - |
Xeroderma pigmentosum, group G;C1851443:Cerebrooculofacioskeletal syndrome 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Jan 14, 2022 | - - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at